SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 41.06 |
Enterprise Value ($M) | 38.07 |
Book Value ($M) | 0.61 |
Book Value / Share | 0.02 |
Price / Book | 67.32 |
NCAV ($M) | 0.02 |
NCAV / Share | 0.00 |
Price / NCAV | 2,535.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -15.21 |
Return on Assets (ROA) | -4.73 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.97 |
Current Ratio | 1.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 6.57 |
Assets | 7.16 |
Liabilities | 6.55 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1.08 |
Operating Income | -20.05 |
Net Income | -20.06 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -16.19 |
Cash from Investing | -0.00 |
Cash from Financing | 23.89 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Armistice Capital, Llc | 4.99 | 45.79 | |
13D/A | Rafael Holdings, Inc. | 49.00 | 5.13 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
13,750 | 52,562 | 26.16 | |
3,010 | 16,466 | 18.28 | |
8,331 | 32,350 | 25.75 | |
192 | 20,592 | 0.93 | |
(click for more detail) |
Similar Companies | |
---|---|
CYCC – Cyclacel Pharmaceuticals, Inc. | CYCN – Cyclerion Therapeutics, Inc. |
CYRX – Cryoport, Inc. | DARE – Daré Bioscience, Inc. |
DERM – Journey Medical Corporation |
Financial data and stock pages provided by
Fintel.io